$41.87
-1.02-2.38%
At Close: -
$42.34
0.471.12%
After Hours: 6:59 PM EDT
15 minutes delayed
Comments
Loading...
Staar Surgical
STAANASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Staar Surgical (NASDAQ:STAA) Stock, Analyst Ratings, Price Targets, Forecasts
Staar Surgical Co has a consensus price target of $59.7 based on the ratings of 14 analysts. The high is $125 issued by Jefferies on August 11, 2022. The low is $37 issued by Morgan Stanley on July 15, 2024. The 3 most-recent analyst ratings were released by BTIG, Morgan Stanley, and BTIG on July 15, 2024, July 15, 2024, and June 11, 2024, respectively. With an average price target of $45.33 between BTIG, Morgan Stanley, and BTIG, there's an implied 7.07% upside for Staar Surgical Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
Morgan Stanley
Canaccord Genuity
Piper Sandler
Mizuho
1calculated from analyst ratings
Analyst Ratings for Staar Surgical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 25.18% | BTIG | Ryan Zimmerman | $46 → $53 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | -12.61% | Morgan Stanley | Patrick Wood | $50 → $37 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/15/2024 | Buy Now | — | Needham | David Saxon | — | Reiterates | → Hold | Get Alert |
| 06/11/2024 | Buy Now | 8.64% | BTIG | Ryan Zimmerman | → $46 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon | — | Reiterates | → Hold | Get Alert |
| 05/08/2024 | Buy Now | 1.56% | Canaccord Genuity | Jon Young | $46 → $43 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | -5.53% | Piper Sandler | Matt O'Brien | $33 → $40 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 29.9% | Mizuho | Anthony Petrone | $53 → $55 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | 25.18% | Mizuho | Anthony Petrone | $45 → $53 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | 8.64% | Canaccord Genuity | Jon Young | $32 → $46 | Maintains | Hold | Get Alert |
| 04/04/2024 | Buy Now | — | Needham | David Saxon | — | Reiterates | → Hold | Get Alert |
| 04/01/2024 | Buy Now | 18.09% | Stifel | Thomas Stephan | $50 → $50 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | 18.09% | Stifel | Thomas Stephan | $30 → $50 | Upgrade | Hold → Buy | Get Alert |
| 02/28/2024 | Buy Now | 6.28% | Mizuho | Anthony Petrone | $50 → $45 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -22.06% | Piper Sandler | Matt O'Brien | $40 → $33 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | — | Needham | David Saxon | — | Downgrade | Buy → Hold | Get Alert |
| 12/04/2023 | Buy Now | -17.34% | Morgan Stanley | Patrick Wood | → $35 | Initiates | → Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | -5.53% | Piper Sandler | Matt O'Brien | $45 → $40 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | 15.73% | Needham | David Saxon | $52 → $49 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | -5.53% | Stifel | Thomas Stephan | $45 → $40 | Maintains | Hold | Get Alert |
| 09/15/2023 | Buy Now | 6.28% | Piper Sandler | Matt O'Brien | $50 → $45 | Maintains | Neutral | Get Alert |
| 09/15/2023 | Buy Now | 53.52% | Mizuho | Anthony Petrone | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | — | Benchmark | Bruce Jackson | — | Downgrade | Buy → Hold | Get Alert |
| 09/15/2023 | Buy Now | 22.82% | Needham | David Saxon | $54 → $52 | Maintains | Buy | Get Alert |
| 09/13/2023 | Buy Now | 53.52% | Mizuho | Anthony Petrone | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | Buy Now | 6.28% | Stifel | Thomas Stephan | → $45 | Reiterates | Hold → Hold | Get Alert |
| 08/21/2023 | Buy Now | 6.28% | Stifel | Thomas Stephan | $50 → $45 | Maintains | Hold | Get Alert |
| 08/14/2023 | Buy Now | 34.62% | Stephens & Co. | George Sellers | → $57 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | 34.62% | Stephens & Co. | George Sellers | $71 → $57 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | 18.09% | Piper Sandler | Matt O'Brien | $65 → $50 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 36.99% | Needham | David Saxon | $75 → $58 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 13.37% | Canaccord Genuity | William Plovanic | $77 → $48 | Downgrade | Buy → Hold | Get Alert |
| 06/12/2023 | Buy Now | 29.9% | Stifel | Thomas Stephan | $60 → $55 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | 81.86% | Canaccord Genuity | William Plovanic | → $77 | Reiterates | → Buy | Get Alert |
| 06/07/2023 | Buy Now | — | William Blair | Margaret Kaczor | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/24/2023 | Buy Now | 77.14% | Needham | David Saxon | → $75 | Reiterates | Buy → Buy | Get Alert |
| 05/04/2023 | Buy Now | 100.76% | Stephens & Co. | George Sellers | → $85 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 98.39% | Needham | David Saxon | $78 → $84 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 53.52% | Piper Sandler | Matt O'Brien | → $65 | Initiates | → Neutral | Get Alert |
| 02/22/2023 | Buy Now | 100.76% | Stephens & Co. | George Sellers | → $85 | Reiterates | → Overweight | Get Alert |
| 02/22/2023 | Buy Now | 84.22% | Needham | David Saxon | $83 → $78 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | — | BTIG | Ryan Zimmerman | — | Downgrade | Buy → Neutral | Get Alert |
| 02/01/2023 | Buy Now | 77.14% | Benchmark | Bruce Jackson | $78 → $75 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | 88.95% | Canaccord Genuity | William Plovanic | $79 → $80 | Maintains | Buy | Get Alert |
| 01/20/2023 | Buy Now | 86.58% | Canaccord Genuity | William Plovanic | $76 → $79 | Maintains | Buy | Get Alert |
| 12/28/2022 | Buy Now | 100.76% | Stephens & Co. | George Sellers | $91 → $85 | Maintains | Overweight | Get Alert |
| 12/08/2022 | Buy Now | 41.71% | Stifel | Thomas Stephan | → $60 | Initiates | → Hold | Get Alert |
| 11/07/2022 | Buy Now | — | Sidoti & Co. | James Sidoti | — | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2022 | Buy Now | 88.95% | BTIG | Ryan Zimmerman | $103 → $80 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 96.03% | Needham | David Saxon | $110 → $83 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 107.84% | Canaccord Genuity | William Plovanic | $97 → $88 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 114.93% | Stephens & Co. | George Sellers | → $91 | Reinstates | → Overweight | Get Alert |
| 10/13/2022 | Buy Now | 100.76% | Mizuho | Anthony Petrone | → $85 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | 195.23% | Jefferies | Zachary Weiner | $165 → $125 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | 176.33% | Benchmark | Bruce Jackson | $97 → $117 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | 159.8% | Needham | David Saxon | $87 → $110 | Maintains | Buy | Get Alert |
| 04/26/2022 | Buy Now | 110.2% | Canaccord Genuity | Jason Mills | $81 → $89 | Maintains | Buy | Get Alert |
| 04/08/2022 | Buy Now | 105.48% | Needham | David Saxon | → $87 | Initiates | → Buy | Get Alert |
| 03/18/2022 | Buy Now | 131.46% | BTIG | Ryan Zimmerman | → $98 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Staar Surgical (STAA) stock?
The latest price target for Staar Surgical (NASDAQ:STAA) was reported by BTIG on July 15, 2024. The analyst firm set a price target for $53.00 expecting STAA to rise to within 12 months (a possible 25.18% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Staar Surgical (STAA)?
The latest analyst rating for Staar Surgical (NASDAQ:STAA) was provided by BTIG, and Staar Surgical maintained their buy rating.
When was the last upgrade for Staar Surgical (STAA)?
The last upgrade for Staar Surgical Co happened on June 11, 2024 when BTIG raised their price target to $46. BTIG previously had a neutral for Staar Surgical Co.
When was the last downgrade for Staar Surgical (STAA)?
The last downgrade for Staar Surgical Co happened on July 15, 2024 when Morgan Stanley changed their price target from $50 to $37 for Staar Surgical Co.
When is the next analyst rating going to be posted or updated for Staar Surgical (STAA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Staar Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Staar Surgical was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating Staar Surgical (STAA) correct?
While ratings are subjective and will change, the latest Staar Surgical (STAA) rating was a maintained with a price target of $46.00 to $53.00. The current price Staar Surgical (STAA) is trading at is $42.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.